GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Revenio Group Oyj (OTCPK:REVXF) » Definitions » Asset Turnover

Revenio Group Oyj (Revenio Group Oyj) Asset Turnover : 0.17 (As of Mar. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Revenio Group Oyj Asset Turnover?

Asset Turnover measures how quickly a company turns over its asset through sales. It is calculated as Revenue divided by Total Assets. Revenio Group Oyj's Revenue for the three months ended in Mar. 2024 was $25.7 Mil. Revenio Group Oyj's Total Assets for the quarter that ended in Mar. 2024 was $150.4 Mil. Therefore, Revenio Group Oyj's Asset Turnover for the quarter that ended in Mar. 2024 was 0.17.

Asset Turnover is linked to ROE % through Du Pont Formula. Revenio Group Oyj's annualized ROE % for the quarter that ended in Mar. 2024 was 14.14%. It is also linked to ROA % through Du Pont Formula. Revenio Group Oyj's annualized ROA % for the quarter that ended in Mar. 2024 was 10.41%.


Revenio Group Oyj Asset Turnover Historical Data

The historical data trend for Revenio Group Oyj's Asset Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Revenio Group Oyj Asset Turnover Chart

Revenio Group Oyj Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Asset Turnover
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.75 0.57 0.64 0.72 0.72

Revenio Group Oyj Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Asset Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.17 0.18 0.17 0.22 0.17

Competitive Comparison of Revenio Group Oyj's Asset Turnover

For the Medical Devices subindustry, Revenio Group Oyj's Asset Turnover, along with its competitors' market caps and Asset Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Revenio Group Oyj's Asset Turnover Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Revenio Group Oyj's Asset Turnover distribution charts can be found below:

* The bar in red indicates where Revenio Group Oyj's Asset Turnover falls into.



Revenio Group Oyj Asset Turnover Calculation

Asset Turnover measures how quickly a company turns over its asset through sales.

Revenio Group Oyj's Asset Turnover for the fiscal year that ended in Dec. 2023 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=105.317/( (144.164+149.851)/ 2 )
=105.317/147.0075
=0.72

Revenio Group Oyj's Asset Turnover for the quarter that ended in Mar. 2024 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=25.652/( (149.851+150.978)/ 2 )
=25.652/150.4145
=0.17

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies with low profit margins tend to have high Asset Turnover, while those with high profit margins have low Asset Turnover. Companies in the retail industry tend to have a very high turnover ratio.


Revenio Group Oyj  (OTCPK:REVXF) Asset Turnover Explanation

Asset Turnover is linked to ROE % through Du Pont Formula.

Revenio Group Oyj's annulized ROE % for the quarter that ended in Mar. 2024 is

ROE %**(Q: Mar. 2024 )
=Net Income/Total Stockholders Equity
=15.652/110.718
=(Net Income / Revenue)*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(15.652 / 102.608)*(102.608 / 150.4145)*(150.4145/ 110.718)
=Net Margin %*Asset Turnover*Equity Multiplier
=15.25 %*0.6822*1.3585
=ROA %*Equity Multiplier
=10.41 %*1.3585
=14.14 %

Note: The Net Income data used here is four times the quarterly (Mar. 2024) net income data. The Revenue data used here is four times the quarterly (Mar. 2024) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** The ROE % used above is for Du Pont Analysis only. It is different from the defined ROE % page on our website, as here it uses Net Income instead of Net Income attributable to Common Stockholders in the calculation.

It is also linked to ROA % through Du Pont Formula:

Revenio Group Oyj's annulized ROA % for the quarter that ended in Mar. 2024 is

ROA %(Q: Mar. 2024 )
=Net Income/Total Assets
=15.652/150.4145
=(Net Income / Revenue)*(Revenue / Total Assets)
=(15.652 / 102.608)*(102.608 / 150.4145)
=Net Margin %*Asset Turnover
=15.25 %*0.6822
=10.41 %

Note: The Net Income data used here is four times the quarterly (Mar. 2024) net income data. The Revenue data used here is four times the quarterly (Mar. 2024) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Therefore, it is a good sign if a company's Asset Turnover is consistent or even increases. If a company's asset grows faster than sales, its Asset Turnover will decline, which can be a warning sign.


Revenio Group Oyj Asset Turnover Related Terms

Thank you for viewing the detailed overview of Revenio Group Oyj's Asset Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


Revenio Group Oyj (Revenio Group Oyj) Business Description

Traded in Other Exchanges
Address
Ayritie 22, Vantaa, FIN, 01510
Revenio Group Oyj is a Finnish health technology company. It develops and commercializes effective and easy-to-use health tech-related screening devices for the detection of diseases of significance to public health. Its ophthalmic diagnostic solutions include intraocular pressure (IOP) measurement devices (tonometers), perimeter and fundus imaging devices under the iCare brand. Its eye care software platform Oculo offers clinical communication, telehealth, remote patient monitoring, and data analytics capabilities. The company's geographical segments include Finland, Other Europe, and Others.

Revenio Group Oyj (Revenio Group Oyj) Headlines

From GuruFocus

Q4 2023 Revenio Group Oyj Earnings Call Transcript

By GuruFocus Research 02-28-2024